Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 26, 2006

Cerus Receives $5M Milestone Payment

  • Cerus received a $5-million cash milestone payment from BioOne triggered by the CE mark regulatory approval for its INTERCEPT Blood System for plasma in Europe. The agreements between Cerus and BioOne provide for milestone payments to Cerus as well as royalties based on sales of the INTERCEPT Blood System for platelets and plasma.

    Cerus also expects an addition payment of BioOne preferred stock worth $5 million in early 2007. Upon receipt of the cash milestone payment, Cerus forwarded $0.5 million to Baxter Healthcare according to an agreement relating to the BioOne commercialization rights.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »